SPPI Spectrum Pharmaceuticals, Inc.

About SPPI

Spectrum Pharmaceuticals, Inc. is a biotechnology company, which engages in the acquisition, development and commercialization of a pipeline of novel and targeted oncology therapies. Its product pipeline includes: Eflapegrastim, Poziotinib, and IGN002. The company was founded in December 1987 and is headquartered in Boston, MA.
57

Bullish Sentiment

How do you feel about SPPI?

Advertisement|Remove ads.